Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · IEX Real-Time Price · USD
0.720
+0.091 (14.54%)
At close: Aug 8, 2022 4:00 PM
0.690
-0.030 (-4.153%)
After-hours:
Aug 8, 2022 6:52 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin
|
10.01 | 8.15 | 4.59 | 7 | 3.36 | 5.79 | 5.56 | 1.36 |
| Research & Development
|
20.4 | 12 | 3.18 | 7.59 | 7.16 | 15.02 | 8.4 | 0.31 |
| Operating Expenses
|
30.4 | 20.15 | 7.77 | 14.59 | 10.52 | 20.81 | 13.96 | 1.67 |
| Operating Income
|
-30.4 | -20.15 | -7.77 | -14.59 | -10.52 | -20.81 | -13.96 | -1.67 |
| Interest Expense / Income
|
0.01 | 0.03 | 0.55 | 0.34 | 0 | 0 | 0 | 0.01 |
| Other Expense / Income
|
2.31 | 0.15 | -0.38 | -4.95 | -1.06 | -3.81 | 8.23 | 3.6 |
| Pretax Income
|
-32.72 | -20.32 | -7.95 | -9.99 | -9.46 | -17 | -22.19 | -5.28 |
| Income Tax
|
0 | 0.03 | -0.91 | -0.54 | -1.95 | 0 | 0 | 0 |
| Net Income
|
-32.72 | -20.35 | -7.04 | -9.45 | -7.51 | -17 | -22.19 | -5.28 |
| Preferred Dividends
|
0 | 0.01 | 5.44 | 8.45 | 0 | 0 | 0 | 0 |
| Net Income Common
|
-32.72 | -20.36 | -12.48 | -17.9 | -7.51 | -17 | -22.19 | -5.28 |
| Shares Outstanding (Basic)
|
70 | 10 | 2 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted)
|
70 | 10 | 2 | 0 | 0 | 0 | 0 | 0 |
| Shares Change
|
626.32% | 373.65% | 1011.19% | 32.99% | 186.13% | 24.39% | 69.72% | - |
| EPS (Basic)
|
-0.47 | -2.10 | -6.11 | -97.35 | -54.60 | -352.80 | -571.20 | -229.60 |
| EPS (Diluted)
|
-0.47 | -2.10 | -6.11 | -97.35 | -54.60 | -352.80 | -571.20 | -229.60 |
| Free Cash Flow Per Share
|
-0.45 | -1.68 | -3.73 | -85.08 | -59.38 | -342.74 | -251.13 | -60.24 |
| Effective Tax Rate
|
0.00% | -0.15% | 11.44% | 5.37% | 20.59% | 0.00% | 0.00% | 0.00% |
| EBITDA
|
-32.63 | -20.26 | -7.36 | -9.63 | -9.45 | -16.98 | -22.18 | -5.27 |
| Depreciation & Amortization
|
0.09 | 0.03 | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | 0 |
| EBIT
|
-32.71 | -20.29 | -7.39 | -9.65 | -9.46 | -17 | -22.19 | -5.27 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).